<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Morbidity and mortality in puerperal <z:hpo ids='HP_0005305'>cerebral venous thrombosis</z:hpo> (CVT) can be reduced by arresting the progression of <z:mp ids='MP_0005048'>thrombosis</z:mp> using <z:chebi fb="5" ids="28304">heparin</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>However, conventional dose of <z:chebi fb="5" ids="28304">heparin</z:chebi> requires monitoring of coagulation parameters and carries a risk of haemorrhage </plain></SENT>
<SENT sid="2" pm="."><plain>The present study involved 56 patients of puerperal CVT with CT evidence of haemorrhagic infarction </plain></SENT>
<SENT sid="3" pm="."><plain>Twenty nine of these patients received low dose <z:chebi fb="5" ids="28304">heparin</z:chebi> till 30th post-partum day or symptomatic relief </plain></SENT>
<SENT sid="4" pm="."><plain>Their clinical features and severity were similar to 27 patients who did not receive <z:chebi fb="5" ids="28304">heparin</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>The mortality and morbidity at discharge was significantly less (P &lt; 0.001) in <z:chebi fb="5" ids="28304">heparin</z:chebi> treated group </plain></SENT>
<SENT sid="6" pm="."><plain>There were no haemorrhagic complications </plain></SENT>
<SENT sid="7" pm="."><plain>Low dose <z:chebi fb="5" ids="28304">heparin</z:chebi> is safe and effective in <z:hpo ids='HP_0005305'>cerebral venous thrombosis</z:hpo>, even with haemorrhagic infarction </plain></SENT>
</text></document>